₹351.60
−0.79%NSE close, 16 Nov 2026
−15.20%
Panacea Biotec is a small cap company, listed on NSE under the symbol PANACEABIO. At ₹351.60 a share, the market values the whole company at ₹2,154 crore.
In FY26, it reported sales of ₹640 crore and a net loss of ₹5 crore, an operating margin of -0.7%. Over the last three years, sales grew 11.6% a year.
The market values the company at 117.0 times its profit over the last twelve months and 2.53 times its book value; its return on equity is 2.2% and it has almost no borrowings.
Promoters hold 72.48% of the shares. Foreign institutions hold 2.75%, and domestic institutions, mutual funds among them, 2.47%.
Over the past year the share price has fallen 14.2%, and it is 45.7% below its 52-week high.
₹ crore. Consolidated figures.
| Line | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 151 | 136 | 116 | 147 | 163 | 133 | 167 | 141 | 165 | 167 | 200 | 190 |
| Expenses | 151 | 143 | 130 | 140 | 156 | 159 | 168 | 159 | 153 | 164 | 194 | 174 |
| Operating profit | −0.2 | −6.0 | −14.0 | 7.0 | 8.0 | −26.9 | −1.2 | −17.8 | 11.7 | 2.6 | 5.7 | 15.5 |
| Operating margin | -0.1% | -4.4% | -12.1% | 4.8% | 4.9% | -20.3% | -0.7% | -12.6% | 7.1% | 1.5% | 2.8% | 8.2% |
| Other income | 5.7 | 10.8 | 3.8 | 4.7 | 3.6 | 8.6 | 5.7 | 6.4 | 2.3 | 2.6 | 4.2 | 6.6 |
| Interest | 0.9 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 0.9 | 2.1 | 1.9 | 1.2 | 1.2 | 0.6 |
| Depreciation | 9.1 | 8.8 | 8.7 | 8.7 | 9.0 | 8.4 | 8.4 | 8.3 | 8.5 | 7.9 | 7.9 | 7.3 |
| Profit before tax | −1.7 | −2.1 | −17.1 | 4.8 | 4.4 | −0.0 | 6.6 | −19.2 | 6.5 | −1.3 | 3.6 | 17.0 |
| Tax | 0.6 | −0.1 | −1.2 | 0.1 | −0.1 | 2.0 | 2.6 | −5.2 | 2.6 | −0.3 | 1.4 | 5.1 |
| Net profit | −2.2 | −1.4 | −15.8 | 4.8 | 4.5 | −1.9 | 4.1 | −13.9 | 4.0 | 0.5 | 2.3 | 11.6 |
| EPS (₹) | -0.37 | -0.23 | -2.59 | 0.77 | 0.74 | -0.31 | 0.66 | -2.27 | 0.65 | 0.08 | 0.38 | 1.90 |
₹ crore, financial years to March.
| Line | FY19 S | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 96.2 | 544 | 625 | 661 | 460 | 559 | 559 | 640 |
| Expenses | 243 | 513 | 548 | 675 | 558 | 579 | 585 | 644 |
| Operating profit | −147 | 31.4 | 76.6 | −13.9 | −98.0 | −20.1 | −25.9 | −4.7 |
| Operating margin | -152.4% | 5.8% | 12.3% | -2.1% | -21.3% | -3.6% | -4.6% | -0.7% |
| Other income | 3.5 | 29.7 | 10.0 | 11.0 | 51.7 | 25.8 | 20.7 | 16.9 |
| Interest | 105 | 174 | 185 | 181 | 4.4 | 3.6 | 3.9 | 6.1 |
| Depreciation | 33.0 | 43.2 | 45.6 | 43.7 | 39.1 | 36.7 | 34.8 | 33.1 |
| Profit before tax | 32.6 | −172 | −144 | 1,449 | 12.8 | 1.5 | −8.0 | −7.4 |
| Tax | 10.6 | 16.6 | 2.0 | 371 | 46.6 | 3.0 | 0.8 | −0.2 |
| Net profit | 26.6 | −194 | −148 | 1,078 | −33.8 | −0.9 | −8.4 | −5.4 |
| EPS (₹) | 4.34 | -31.72 | -24.11 | 175.98 | -5.52 | -0.16 | -1.37 | -0.88 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −108 | −27.4 | 16.7 | 23.4 |
| From investing | 1,283 | 65.0 | −40.5 | −31.4 |
| From financing | −1,176 | −2.7 | −1.1 | 10.1 |
| Spent on fixed assets | −12.5 | −50.3 | −54.1 | −13.8 |
| Free cash flow | −121 | −77.7 | −37.4 | 9.6 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 27.6% | -35.7% | -23.6% | 163.0% | -7.3% | -0.2% | -1.5% | -0.8% |
| Operating margin | -152.4% | 5.8% | 12.3% | -2.1% | -21.3% | -3.6% | -4.6% | -0.7% |
| Return on equity | – | – | – | – | -4.0% | -0.1% | -1.0% | -0.6% |
| Return on capital employed | – | – | – | – | 2.0% | 0.6% | -0.5% | -0.2% |
| Return on assets | – | – | – | – | -2.7% | -0.1% | -0.7% | -0.4% |
| Debt to equity | – | – | – | – | 0.02 | 0.02 | 0.03 | 0.03 |
| Interest coverage | 1.30 | 0.00 | 0.20 | 9.00 | 3.90 | 1.40 | -1.00 | -0.20 |
| Debt to assets | – | – | – | – | 0.02 | 0.02 | 0.02 | 0.02 |
| Current ratio | – | – | – | – | 1.71 | 1.57 | 1.49 | 1.47 |
| Quick ratio | – | – | – | – | 1.09 | 0.99 | 0.90 | 0.92 |
| Cash ratio | – | – | – | – | 0.12 | 0.15 | 0.22 | 0.16 |
| Asset turnover | – | – | – | – | 0.36 | 0.45 | 0.43 | 0.51 |
| Fixed asset turnover | – | – | – | – | 0.78 | 1.00 | 1.03 | 1.16 |
| Inventory turnover | – | – | – | – | – | 1.30 | 0.90 | 1.50 |
| Receivables turnover | – | – | – | – | 7.70 | 9.70 | 7.70 | 8.70 |
| Gross margin | – | – | – | – | – | 58.8% | 64.3% | 56.2% |
| Cash from operations to profit | – | – | – | -10.0% | – | – | – | – |
| Effective tax rate | 32.6% | – | – | 25.6% | 363.7% | 201.4% | – | – |
The financial results for the period ended September 30, 2026.
Details of Shares dematerialized during October 2026
Details of Shares dematerialized during September 2026
A copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 29, 2026
General Updates - Book closure for the purpose of AGM
General Updates - Confirmation on letter being sent to the concerned shareholders providing the weblink for accessing the Annual Report for financial year 2025-26 and the Notice of the ensuing AGM, to be held on September 29, 2026, through Video Conferencing / Other…
Notice of Annual General Meeting to be held on September 29, 2026
Details of Shares dematerialized during August 2026
The financial results for the period ended Jun 30, 2026.
Details of Shares dematerialized during July 2026